Home›Stock Screener›Ambar Protein Industries›Financial Statements

Ambar Protein Industries Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Ambar Protein Industries (AMBARPIL) reported revenue ₹501 Cr, net profit ₹7 Cr and EPS ₹12.22, with a net profit margin of 1.4% and ROE of 20.0%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Also explore AMBARPIL price movement history to track price trends across different timeframes.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 1.40% 2026 data
EBITDA Margin 2.40% 2026 data
Operating Margin 2.00% 2026 data
Return on Assets 9.86% 2026 data
Return on Equity 20.00% 2026 data

Balance Sheet Ratios

Current Ratio 16.00 2026 data
Equity Ratio 49.30% 2026 data
Asset Turnover 7.06 2026 data

AMBARPIL Revenue, Net Profit & EBITDA — Year-on-Year Growth

AMBARPIL YoY (March 2025 vs March 2026) — revenue +18.4%, net profit -30.0%, EBITDA -29.4%, expenses +20.4%. Analyse AMBARPIL institutional holdings to track promoter, FII and institutional holdings.

Revenue Growth
+18.4%
Year-over-Year
Net Profit Growth
-30.0%
Year-over-Year
EBITDA Growth
-29.4%
Year-over-Year
Expense Growth
+20.4%
Year-over-Year
Assets Growth
+16.4%
Year-over-Year
Equity Growth
+40.0%
Year-over-Year
Operating Cash Flow Growth
-71.4%
Year-over-Year
Financing Cash Flow Growth
+71.4%
Year-over-Year

AMBARPIL Income Statement — Revenue, EBITDA & Net Profit

Ambar Protein Industries revenue ₹501 Cr, EBITDA ₹12 Cr, net profit ₹7 Cr, EPS ₹12.22 (2026) — net profit margin 1.4%. For live price, earnings ratios and company overview, see Ambar Protein Industries share price screener.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 501 423 338 346 340 314 285 231 207 196 169 158
Expenses 489 406 330 338 331 306 278 227 203 193 167 155
EBITDA 12 17 8 8 10 8 7 4 4 3 2 3
Operating Profit Margin % 2.00% 4.00% 2.00% 2.00% 3.00% 2.00% 2.00% 2.00% 1.00% 1.00% 1.00% 1.00%
Depreciation 1 1 1 1 1 1 1 0 0 0 0 0
Interest 2 2 3 3 3 3 3 1 1 1 1 1
Profit Before Tax 9 13 4 4 6 4 3 3 3 3 1 2
Tax 2 3 1 1 2 1 2 1 1 0 1 0
Net Profit 7 10 3 3 5 3 1 2 2 2 1 2
Earnings Per Share (₹) 12.22 16.78 5.47 4.89 7.74 6.00 2.17 3.54 3.75 4.19 1.51 2.70

AMBARPIL Balance Sheet — Assets, Liabilities & Shareholders' Equity

AMBARPIL total assets ₹71 Cr, total equity ₹35 Cr, total liabilities ₹ Cr (2025) — ROE 20.0%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 71 61 62 64 50 49 53 31 23 17 13
Current Assets 48 41 41 44 29 27 31 19 17 10 8
Fixed Assets 18 19 20 21 21 22 7 6 6 6 4
Capital Work in Progress 1 0 0 0 0 0 16 6 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0
Other Assets 51 42 42 44 29 27 31 19 17 12 9
LIABILITIES
Total Liabilities
Current Liabilities 3 3 5 6 7 8 8 5 2 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 35 25 22 19 15 11 10 8 6 6 4
Share Capital 6 6 6 6 6 6 6 6 6 7 7
Reserves & Surplus 29 19 16 13 9 5 4 2 0 -1 -3

AMBARPIL Cash Flow Statement — Operating, Investing & Financing

Ambar Protein Industries operating cash flow ₹2 Cr, investing ₹0 Cr, financing ₹-2 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 2 7 6 -3 1 3 1 1 -3 -1 1
Investing Activities 0 0 0 0 0 -1 -10 -5 0 -1 1
Financing Activities -2 -7 -6 3 -3 0 7 6 3 1 -1
Net Cash Flow 0 0 0 0 -1 1 -2 1 1 -1 0